Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 20, Issue 3, 2001, Pages 316-321

  Grauhan, Onnen ^a   Knosalla, Christoph ^a   Ewert, Ralf ^a   Hummel, Manfred ^a   Loebe, Matthias ^a   Weng, Yu Guo ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOMES RESEARCH; PLASMAPHERESIS; PRIORITY JOURNAL; SURVIVAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PLASMAPHERESIS;

EID: 0035112190     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00211-4     Document Type: Article

References (26)

1. Passive transfer of transplantation immunity
2. Passive transfer of transplantation immunity; I. Tritiated lymphoid cells. II. Lymphoid cells in millipore chambers
3. Heart-reactive antibody; an index of cardiac rejection in human heart transplantation
4. Percutaneous transvenous endomyocardial biopsy in human heart recipients
5. Diagnosis of cardiac rejection by endomyocardial biopsy
6. Acute humoral rejection after heart transplantation
7. Vascular (humoral) rejection in heart transplantation; pathological observations and clinical implications
8. Immunofluorescence of endomyocardial biopsy specimens; methods and interpretation
9. Vascular (humoral) rejection in human cardiac allograft biopsies; relation to circulating anti-HLA antibodies
10. Clinical manifestations of vascular rejection in cardiac transplantation
11. Vascular rejection in heart transplant recipients
12. Vascular rejection in heart transplantation; clinical correlation, treatment options, and future considerations
13. Successful treatment of acute humoral rejection in a heart transplant patient
14. Heart transplant rejection treated with plasmapheresis
15. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch; preliminary results with plasmapheresis
16. Plasmapheresis in the treatment of posttransplant cardiomyopathy
17. Plasmapheresis as a therapy to resolve vascular rejection in heart transplantation with severe heart failure; a report of one case
18. Apheresis in thoracic organ transplantation
19. Accelerated course of cardiac allograft rejection after mechanical bridging
20. Impact of apheresis and cyclophosphamide in the treatment of vascular rejection following heart transplantation
21. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection; Heart Rejection Study Group
22. Clinical heart transplantation without routine endomyocardial biopsy
23. Humoral rejection after heart transplantation; reliability of intramyocardial electrogram recordings (IMEG) and myocardial biopsy
24. Intramyocardial electrogram recordings for diagnosis and therapy monitoring of cardiac allograft rejection
25. Early diastolic left ventricular function as a marker of acute cardiac rejection; a prospective serial echocardiographic study